Neurocrine Biosciences, Inc.

NASDAQ:NBIX  
93.09
+3.25 (+3.62%)
Other Pre-Announcement

Neurocrine Biosciences Reports First Quarter 2022 Financial Results And Reiterates 2022 Financial Guidance

Published: 05/04/2022 12:16 GMT
Neurocrine Biosciences, Inc. (NBIX) - Neurocrine Biosciences Reports First Quarter 2022 Financial Results and Reiterates 2022 Financial Guidance.
Qtrly Non-GAAP Earnings per Share $ 0.30.
Qtrly GAAP Earnings per Share $ 0.14.
Qtrly Total Revenues $ 310.6 Million Versus $236.6 Million.
Q1 Earnings per Share View $0.35, Revenue View $304.2 Million -- Refinitiv Ibes Data (analyst estimates).